Jiangsu Hengrui Medicine
600276.SS
#466
Rank
S$58.27 B
Marketcap
$9.14
Share price
-1.00%
Change (1 day)
1.28%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Cash on Hand

Cash on Hand as of September 2024 : S$4.31 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company has S$4.31 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Jiangsu Hengrui Medicine - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$3.47 B-12.54%
2021-12-31S$3.97 B19.16%
2020-12-31S$3.33 B27.33%
2019-12-31S$2.61 B18.08%
2018-12-31S$2.21 B152.69%
2017-12-31S$0.87 B-14.32%
2016-12-31S$1.02 B-8.61%
2015-12-31S$1.12 B52.22%
2014-12-31S$0.73 B62.07%
2013-12-31S$0.45 B74.15%
2012-12-31S$0.26 B33.3%
2011-12-31S$0.19 B0.92%
2010-12-31S$0.19 B33.35%
2009-12-31S$0.14 B48.86%
2008-12-31S$97.64 M-41.33%
2007-12-31S$0.16 B46.96%
2006-12-31S$0.11 B27.2%
2005-12-31S$89.03 M24.12%
2004-12-31S$71.73 M73.58%
2003-12-31S$41.32 M3%
2002-12-31S$40.12 M-33.8%
2001-12-31S$60.6 M-40.15%
2000-12-31S$0.10 B407.36%
1999-12-31S$19.95 M249.61%
1998-12-31S$5.7 M6.41%
1997-12-31S$5.36 M